ConductScience.org, home

Paper1237176

Neutralizing antibodies after rubella vaccination of newly delivered women: a comparison between three vaccines.

Grillner L. Scand J Infect Dis, 1975. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. Neutralizing antibodies after rubella vaccination of newly delivered women: a comparison between three vaccines. Papers, record 1237176. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1237176

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neutralizing antibodies after rubella vaccination of newly delivered women: a comparison between three vaccines.
PubMed
Journal
Scand J Infect Dis
PubMed
Year
1975
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
1.53
iCite
Revised in PubMed
2019-08-24
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grillner LL

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, ViralMajor topic
Antibody FormationMajor topic
Rubella VaccineMajor topic
Delivery, Obstetric
Female
Hemagglutination Inhibition Tests
Humans
Neutralization Tests
Pregnancy
Rubella
Rubella virus
Time Factors

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
17215337Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination.Clin Vaccine Immunol2007https://conductscience.org/library/papers/17215337PubMed
8862587Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals.J Clin Microbiol1996https://conductscience.org/library/papers/8862587PubMed
7153314Comparison of the latex agglutination test with the hemagglutination inhibition test, enzyme-linked immunosorbent assay, and neutralization test for detection of antibodies to rubella virus.J Clin Microbiol1982https://conductscience.org/library/papers/7153314PubMed
767364Evaluation of the hemolysis-in-gel test for the screening of rubella immunity and the demonstration of recent infection.J Clin Microbiol1976https://conductscience.org/library/papers/767364PubMed
649946Antibody titres in women six to eight years after the administration of RA2713 and Cendehill rubella vaccines.J Hyg (Lond)1978https://conductscience.org/library/papers/649946PubMed
266542Rubella in Orkney: seroepidemiology and vaccination.J Hyg (Lond)1977https://conductscience.org/library/papers/266542PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1237176

GET https://conductscience.org/api/papers/v1/1237176/authors